Status:
COMPLETED
Platelet Inhibition in the Acute Phase of STEMI
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
AP Moeller Foundation
Conditions:
Acute Myocardial Infarction
Antiplatelet Therapy
Eligibility:
All Genders
18+ years
Brief Summary
Background: Dual antithrombotic treatment with aspirin and clopidogrel is recommended in patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention...
Eligibility Criteria
Inclusion
- Above 18 years of age
- Patients with ST-segment elevation myocardial infarction (STEMI) referred to primary PCI at University Hospital of Aarhus, Skejby.
Exclusion
- Treatment with NSAID, ticlopidine and dipyramidole.
- Treatment with anticoagulants (Vitamin K antagonists)
- Patients diagnosed with platelet disease or haemophilia.
- Patients unable to give written, informed consent to participation in this project.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01144819
Start Date
October 1 2009
End Date
August 1 2010
Last Update
September 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, Skejby
Aarhus N, Central Jutland, Denmark, 8200